AR rs121908753: Understanding Androgen Receptor Variants
The rs121908753 variant is a rare genetic alteration located within the AR gene, which provides instructions for the androgen receptor protein. This specific variant is associated with androgen insensitivity syndrome (AIS), a condition where the body's cells are unable to respond to androgen hormones.
What each genotype means
Typical androgen receptor function
This genotype represents the common, non-pathogenic sequence for this specific location in the AR gene. Individuals with this genotype do not carry the specific pathogenic mutation associated with androgen insensitivity syndrome at this site.
This is the most common genotype found in the general population across all ancestries.
Androgen insensitivity syndrome carrier
This genotype indicates the presence of a pathogenic variant in the AR gene, which is located on the X chromosome. In XY individuals, this variant is associated with impaired androgen receptor function and androgen insensitivity syndrome; XX individuals are typically asymptomatic carriers but may pass the variant to offspring. Please discuss these results with a genetic counselor or clinician to understand the implications for your health or family planning.
This genotype is ultra-rare in the general population.
Androgen insensitivity syndrome
This genotype indicates the presence of a pathogenic variant in the AR gene, which is known to cause androgen insensitivity syndrome by impairing ligand binding. In XY individuals, this can lead to a range of clinical presentations from complete to partial androgen insensitivity. Please consult with a medical specialist or endocrinologist to discuss the clinical significance of this finding.
This genotype is ultra-rare in the general population.
What is the rs121908753 Variant?
The rs121908753 variant is a specific change in the DNA sequence of the AR gene. In genomics, a variant like this represents a deviation from the most common sequence found in the human population. Because the AR gene is located on the X chromosome, the impact of such variants depends heavily on an individual's sex chromosomes. In individuals with an XY karyotype, there is only one copy of the X chromosome, meaning any variant present in the AR gene will be expressed without a second, functional copy to compensate. This variant is categorized as a pathogenic mutation in clinical databases, meaning it is strongly linked to a specific clinical presentation. It is identified through molecular testing, such as sequencing, which allows clinicians to pinpoint the exact location of the change within the gene's structure.
The Role of the AR Gene
The AR gene encodes the androgen receptor, a protein that acts as a transcription factor. This receptor is essential for the body to respond to androgens, which are hormones like testosterone that play a critical role in male sexual development and the maintenance of various physiological functions. The androgen receptor protein has three primary functional domains: the N-terminal domain, the DNA-binding domain, and the hormone-binding domain. When androgens bind to the receptor, the complex moves into the cell nucleus to regulate the expression of specific genes. If the AR gene contains a pathogenic variant, the resulting receptor protein may be malformed, unstable, or unable to bind to hormones effectively. This disruption prevents the necessary signals for typical male sexual development from being transmitted, which is the underlying mechanism of androgen insensitivity syndrome.
Research and Clinical Associations
Scientific research has established a clear link between pathogenic variants in the AR gene and the spectrum of androgen insensitivity syndrome. The evidence for rs121908753 is considered moderate to strong in clinical contexts, as it is classified as pathogenic in databases like ClinVar. Studies have shown that mutations in the hormone-binding domain, where many pathogenic variants reside, often lead to complete or partial androgen insensitivity. The clinical presentation can vary significantly depending on the specific nature of the mutation and the amount of residual receptor function. While researchers have identified over 1,000 different variants in the AR gene, each contributes differently to the cellular insensitivity to androgens. It is important to note that clinical diagnosis is based on a combination of genetic findings, physical examination, and hormonal profiles, rather than the presence of a single variant alone.
Population Frequency and Prevalence
The rs121908753 variant is classified as ultra-rare in the general population. Because it is associated with a specific clinical condition, it is not typically found in large-scale population databases at high frequencies. Most individuals who carry this variant are identified through clinical diagnostic testing after presenting with symptoms related to androgen insensitivity. Its rarity means that it does not have a significant presence in the general, healthy population. The distribution of such variants is often sporadic, appearing in families or individuals without a prior history of the condition. Because the variant is so uncommon, population-wide screening is not standard practice. Instead, genetic testing is usually reserved for individuals who show clinical signs that warrant investigation into the AR gene.
Navigating Genetic Information
Understanding a genetic variant like rs121908753 requires careful interpretation within a clinical context. If you or a family member have received information about this variant, it is essential to consult with a genetic counselor or a medical specialist, such as an endocrinologist. These professionals can help explain what the variant means for your specific health situation and discuss the implications for family members. Genetic information is complex, and the presence of a variant does not always dictate a specific health outcome without considering the broader clinical picture. You should never use genetic data to self-diagnose or make medical decisions without professional guidance. Always discuss any concerns about your genetic results with a qualified healthcare provider who can provide personalized advice based on your medical history and clinical presentation.
How common is this variant?
The rs121908753 variant is ultra-rare and is not commonly observed in general population databases, as it is primarily identified in clinical settings.
Frequently asked questions
What is androgen insensitivity syndrome?
Androgen insensitivity syndrome is a condition that affects sexual development before birth and during puberty. It occurs when an individual who is genetically male (with one X and one Y chromosome) is unable to respond to certain male sex hormones called androgens.
Is rs121908753 a common genetic variant?
No, rs121908753 is considered an ultra-rare variant. It is not found in the general population at significant frequencies and is typically only identified in individuals undergoing clinical genetic testing.
Can I be tested for this variant?
Genetic testing for AR gene variants is typically performed in a clinical setting when a healthcare provider suspects androgen insensitivity syndrome. You should discuss the necessity and implications of such testing with a genetic counselor or specialist.
What should I do if I have this variant?
If you have been identified as a carrier of this variant, it is important to consult with a medical professional, such as an endocrinologist or a geneticist. They can provide appropriate clinical management and explain what this means for your health.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908753?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in AR
Androgen receptor locus variant on chromosome X strongly associated with early-onset androgenetic alopecia (male pattern baldness).
Intronic variant at the androgen receptor locus associated with hereditary male pattern baldness.
This variant in the androgen receptor gene is associated with androgen insensitivity and has been linked to variations in human adult height.
Pathogenic substitution in the androgen receptor gene leading to partial or complete androgen insensitivity syndrome and male infertility.
Androgen receptor variant associated with male-pattern (androgenetic) hair loss.
Point mutation in AR causing mild androgen insensitivity syndrome, presenting with impaired spermatogenesis and male infertility.
